Published in Arch Intern Med on March 01, 1984
Toxicity and therapeutic effects in mice of liposome-encapsulated nystatin for systemic fungal infections. Antimicrob Agents Chemother (1987) 1.26
Primary prophylaxis of invasive fungal infections in patients with hematologic malignancies. Recommendations of the Infectious Diseases Working Party of the German Society for Haematology and Oncology. Haematologica (2008) 1.24
Antifungal prophylaxis during neutropenia and immunodeficiency. Clin Microbiol Rev (1997) 1.16
Torulopsis glabrata: azole susceptibilities by microdilution colorimetric and macrodilution broth assays. J Clin Microbiol (1995) 1.06
Randomized trial of the addition of gram-positive prophylaxis to standard antimicrobial prophylaxis for patients undergoing autologous bone marrow transplantation. Antimicrob Agents Chemother (1994) 0.83
A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med (2005) 17.06
A randomized, controlled trial of the effects of remote, intercessory prayer on outcomes in patients admitted to the coronary care unit. Arch Intern Med (1999) 12.85
Nosocomial infection by gentamicin-resistant Streptococcus faecalis. An epidemiologic study. Ann Intern Med (1987) 5.74
Induction of proteins in response to low temperature in Escherichia coli. J Bacteriol (1987) 5.55
Methicillin-resistant Staphylococcus aureus: a consensus review of the microbiology, pathogenesis, and epidemiology with implications for prevention and management. Am J Med (1993) 4.72
Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy. Clin Infect Dis (2001) 4.01
Group C streptococcal bacteremia: analysis of 88 cases. Rev Infect Dis (1991) 3.88
Epidemiology of oral candidiasis in HIV-infected patients: colonization, infection, treatment, and emergence of fluconazole resistance. Am J Med (1994) 3.32
Methicillin-resistant Staphylococcus aureus: colonization and infection in a long-term care facility. Ann Intern Med (1991) 3.03
International Conference for the Development of a Consensus on the Management and Prevention of Severe Candidal Infections. Clin Infect Dis (1997) 2.78
Procedural outcomes and long-term survival among patients undergoing percutaneous coronary intervention of a chronic total occlusion in native coronary arteries: a 20-year experience. J Am Coll Cardiol (2001) 2.75
NIAID Mycoses Study Group Multicenter Trial of Oral Itraconazole Therapy for Invasive Aspergillosis. Am J Med (1994) 2.60
Use of a colorimetric system for yeast susceptibility testing. J Clin Microbiol (1995) 2.54
Cold shock and adaptation. Bioessays (1998) 2.39
The impact of culture isolation of Aspergillus species: a hospital-based survey of aspergillosis. Clin Infect Dis (2001) 2.25
Family of the major cold-shock protein, CspA (CS7.4), of Escherichia coli, whose members show a high sequence similarity with the eukaryotic Y-box binding proteins. Mol Microbiol (1994) 2.15
Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting. Eur J Clin Microbiol Infect Dis (2007) 2.09
Structure of vancomycin and its complex with acetyl-D-alanyl-D-alanine. Nature (1978) 2.09
Achromobacter xylosoxidans bacteremia: report of four cases and review of the literature. Clin Infect Dis (1996) 2.09
Tibial stress reaction in runners. Correlation of clinical symptoms and scintigraphy with a new magnetic resonance imaging grading system. Am J Sports Med (1995) 2.08
Practice guidelines for the management of patients with blastomycosis. Infectious Diseases Society of America. Clin Infect Dis (2000) 2.08
Alopecia associated with fluconazole therapy. Ann Intern Med (1995) 2.05
Itraconazole therapy for blastomycosis and histoplasmosis. NIAID Mycoses Study Group. Am J Med (1992) 2.01
DNA double helical fragment at atomic resolution. Nature (1978) 1.96
Staphylococcus aureus nasal colonization in a nursing home: eradication with mupirocin. Infect Control Hosp Epidemiol (1990) 1.90
Single-concentration broth microdilution test for detection of high-level aminoglycoside resistance in enterococci. J Clin Microbiol (1987) 1.85
Identification of chromosomal location of mupA gene, encoding low-level mupirocin resistance in staphylococcal isolates. Antimicrob Agents Chemother (1996) 1.83
Candiduria: a randomized, double-blind study of treatment with fluconazole and placebo. The National Institute of Allergy and Infectious Diseases (NIAID) Mycoses Study Group. Clin Infect Dis (2000) 1.80
Methicillin-resistant Staphylococcus aureus (MRSA): a briefing for acute care hospitals and nursing facilities. The AHA Technical Panel on Infections Within Hospitals. Infect Control Hosp Epidemiol (1994) 1.79
Acquisition of Clostridium difficile from the hospital environment. Am J Epidemiol (1988) 1.69
Coincident development of sesamoid bones and clues to their evolution. Anat Rec (1999) 1.64
Steady-state pharmacokinetics of delavirdine in HIV-positive patients: effect on erythromycin breath test. Clin Pharmacol Ther (1997) 1.64
Gentamicin resistance plasmids of enterococci from diverse geographic areas are heterogeneous. J Infect Dis (1988) 1.60
Failure to respond to influenza vaccine in the aged: correlation with B-cell number and function. J Lab Clin Med (1978) 1.57
Histoplasmosis in immunosuppressed patients. Am J Med (1978) 1.54
The epidemiology of pseudallescheriasis complicating transplantation: nosocomial and community-acquired infection. Mycoses (1990) 1.53
Purulent pneumococcal pericarditis. A continuing problem in the antibiotic era. Am J Med (1973) 1.51
Clostridium difficile colitis associated with cancer chemotherapy. Arch Intern Med (1982) 1.51
Cell-mediated immunity in humans during viral infection. I. Effect of rubella on dermal hypersensitivity, phytohemagglutinin response, and T lymphocyte numbers. Infect Immun (1974) 1.50
High-level aminoglycoside-resistant enterococci. Colonization of nursing home and acute care hospital patients. Arch Intern Med (1987) 1.49
Need for alternative trial designs and evaluation strategies for therapeutic studies of invasive mycoses. Clin Infect Dis (2001) 1.48
Torulopsis glabrata renal infection. Am J Med (1974) 1.48
Increasing resistance of Staphylococcus aureus to ciprofloxacin. Antimicrob Agents Chemother (1990) 1.45
Risk factors for colonization with yeast species in a Veterans Affairs long-term care facility. J Am Geriatr Soc (1998) 1.45
Intermittent urethral catheterization in the elderly. J Am Geriatr Soc (1989) 1.43
Detection and characterization of mupirocin resistance in Staphylococcus aureus. Antimicrob Agents Chemother (1993) 1.43
Bone marrow toxicity associated with 5-fluorocytosine therapy. Antimicrob Agents Chemother (1977) 1.42
Group B streptococcal prosthetic joint infection following sigmoidoscopy. Clin Infect Dis (1992) 1.42
Necrotising fasciitis: a single centre's experience. N Z Med J (1995) 1.40
Increasing resistance of enterococci to ciprofloxacin. Antimicrob Agents Chemother (1992) 1.40
Transmyocardial CO(2) laser revascularization improves symptoms, function, and quality of life: 12-month results from a randomized controlled trial. Am J Med (2001) 1.40
CspA, the major cold shock protein of Escherichia coli, negatively regulates its own gene expression. J Bacteriol (1997) 1.40
Alternated versus syncopated CHOP-PVB: two studies for the treatment of non-Hodgkin's lymphoma by the Southwest Oncology Group. Cancer Invest (1991) 1.39
Observation of an antimatter hypernucleus. Science (2010) 1.38
Differential thermoregulation of two highly homologous cold-shock genes, cspA and cspB, of Escherichia coli. Genes Cells (1996) 1.37
Treatment of blastomycosis with fluconazole: a pilot study. The National Institute of Allergy and Infectious Diseases Mycoses Study Group. Clin Infect Dis (1995) 1.37
Emergence of nosocomial methicillin-resistant Staphylococcus aureus and therapy of colonized personnel during a hospital-wide outbreak. Infect Control (1987) 1.36
Loss of 4.5S RNA induces the heat shock response and lambda prophage in Escherichia coli. J Bacteriol (1990) 1.36
Cryptococcus laurentii lung abscess. Am Rev Respir Dis (1981) 1.35
Nasal carriage of and infection with Staphylococcus aureus in HIV-infected patients. Ann Intern Med (1999) 1.32
Itraconazole prophylaxis for fungal infections in patients with advanced human immunodeficiency virus infection: randomized, placebo-controlled, double-blind study. National Institute of Allergy and Infectious Diseases Mycoses Study Group. Clin Infect Dis (1999) 1.32
Rapid identification of Staphylococcus aureus by using lysostaphin sensitivity. J Clin Microbiol (1980) 1.30
Enterococcal superinfection in patients treated with ciprofloxacin. J Antimicrob Chemother (1988) 1.29
Structure of TANDEM and its implication for bifunctional intercalation into DNA. Nature (1981) 1.29
Colonization and infection with antibiotic-resistant bacteria in a long-term care facility. J Am Geriatr Soc (1994) 1.29
Effect of viral and bacterial pneumonias on cell-mediated immunity in humans. Infect Immun (1976) 1.29
Cardiobacterium hominis endocarditis: Two cases and a review of the literature. Eur J Clin Microbiol Infect Dis (2006) 1.28
Evaluation of the BACTEC antimicrobial removal system for detection of bacteremia. J Clin Microbiol (1983) 1.27
Biliary cryptosporidiosis in HIV-infected people after the waterborne outbreak of cryptosporidiosis in Milwaukee. N Engl J Med (1996) 1.25
Species-specific in vitro pharmacological effects of the cannabinoid receptor 2 (CB2) selective ligand AM1241 and its resolved enantiomers. Br J Pharmacol (2007) 1.24
Radioligand receptor assay for 25-hydroxyvitamin D2/D3 and 1 alpha, 25-dihydroxyvitamin D2/D3. J Clin Invest (1976) 1.22
Association of glenoid labral cysts with labral tears and glenohumeral instability: radiologic findings and clinical significance. Radiology (1994) 1.22
Alterations in gastric acidity in patients infected with human immunodeficiency virus. Clin Infect Dis (1995) 1.21
Pulmonary cryptococcosis in patients without HIV infection: factors associated with disseminated disease. Eur J Clin Microbiol Infect Dis (2008) 1.20
Fungaemia due to Cryptococcus laurentii and a review of non-neoformans cryptococcaemia. Mycoses (1999) 1.20
Association of Reye's syndrome with viral infection. Lancet (1974) 1.17
Tuberculous tenosynovitis of the flexor tendons of the wrist: MR imaging with pathologic correlation. Skeletal Radiol (1996) 1.13
Cellular immune response to cytomegalovirus infection after renal transplantation. Infect Immun (1978) 1.13
Salmonella meningitis. Occurrence in an adult. Arch Neurol (1979) 1.13
Elliptic flow of charged particles in Pb-Pb collisions at sqrt[S(NN)] = 2.76 TeV. Phys Rev Lett (2010) 1.12
Superinfection with Streptococcus pneumoniae during therapy with ciprofloxacin. Am J Med (1990) 1.12
Particle-yield modification in jetlike azimuthal dihadron correlations in Pb-Pb collisions at √s(NN)=2.76 TeV. Phys Rev Lett (2012) 1.11
Blood hemostasis in exercise and training. Med Sci Sports Exerc (2000) 1.11
Bilateral stress fractures of the anterior part of the tibial cortex. A case report. J Bone Joint Surg Am (2000) 1.11
Detection of cryptococcal antigen. Comparison of two latex agglutination tests. Am J Clin Pathol (1981) 1.11
Outbreak of sternal surgical site infections due to Pseudomonas aeruginosa traced to a scrub nurse with onychomycosis. Clin Infect Dis (2001) 1.10
Mupirocin resistance: clinical and molecular epidemiology. Infect Control Hosp Epidemiol (1995) 1.10
Rhodotorula fungaemia: a life-threatening complication of indwelling central venous catheters. Mycoses (1993) 1.10
Hospital-acquired infective endocarditis. Arch Intern Med (1988) 1.09
Trends in species causing fungaemia in a tertiary care medical centre over 12 years. Mycoses (2001) 1.09
Effect of aztreonam on throat and stool flora of cancer patients. Antimicrob Agents Chemother (1984) 1.08
MR imaging of cyclops lesions. AJR Am J Roentgenol (2000) 1.08
Transverse momentum distribution and nuclear modification factor of charged particles in p+Pb collisions at sqrt[s(NN)] = 5.02 TeV. Phys Rev Lett (2013) 1.08
Azole resistance in oropharyngeal Candida albicans strains isolated from patients infected with human immunodeficiency virus. Antimicrob Agents Chemother (1994) 1.07
Torulopsis glabrata: azole susceptibilities by microdilution colorimetric and macrodilution broth assays. J Clin Microbiol (1995) 1.06
Induction of the Cyp1a-1 dioxin-responsive enhancer in transgenic mice. Nucleic Acids Res (1991) 1.06
Cell-mediated immunity in patients on long-term haemodialysis. Clin Exp Immunol (1975) 1.06
Meniscal tears of the knee: accuracy of detection with fast spin-echo MR imaging and arthroscopic correlation in 293 patients. Radiology (1997) 1.05